Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 6781-6790 Newer>

The Motley Fool October 13, 2010 Matt Koppenheffer	Novavax Shares Popped: What You Need to Know Shares of biopharmaceuticals small fry Novavax jumped more than 10% in intraday trading on heavy volume.
Pharmaceutical Executive September 1, 2010	Pharm Exec's Ninth Annual Industry Audit Professor Bill Trombetta takes a snapshot of the "Glamour 24" companies shaping the pharma industry this year and beyond.
Pharmaceutical Executive September 1, 2010	Is There a Balm for Gilead? A new leader, a big acquisition, and a bold investment in HIV may all be in the works at Gilead. But what will it take to restore the glory days?
Pharmaceutical Executive September 1, 2010	Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development.
Pharmaceutical Executive September 1, 2010	Finding the Hidden Behavior Solutions When neither attitudes nor personality drive behavior, Pharma must look to social norms to understand consumer adherence issues.
Pharmaceutical Executive September 1, 2010	Three Little Pigs of Deceptive Advertising If companies aren't careful with their marketing spend, they could, in fact, wind up getting too much bang for their buck
Pharmaceutical Executive September 1, 2010	To Brand or Not to Brand? The effectiveness of direct-to-consumer prescription advertising hinges on a consumer's thirst for information. A new study intimates the less info consumers are given up front, the more they seem willing to learn.
Pharmaceutical Executive September 1, 2010	Maintaining a Culture of Compliance In order to sustain compliance it must become a core component of every company's training, sales processes, and incentive programs.
Pharmaceutical Executive September 1, 2010	Where Prescribing Oncologists Go for Their Information, and Why Marketers need to understand how informal influencers are beginning to replace traditional channels as the favored way for doctors to receive product information from drug manufacturers, and, in turn, how best to leverage peer influence in designing effective meetings and events.
Pharmaceutical Executive September 1, 2010 Marylyn Donahue	With a Little Help from their Peers Physician meetings drive prescribing behavior, but what are the marketing meetings doctors prefer, and who are they listening to?
<Older 6781-6790 Newer> Return to current articles.